These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4005693)

  • 1. Malignant hyperthermia.
    Britt BA
    Can Anaesth Soc J; 1985 May; 32(3 Pt 2):S40-1. PubMed ID: 4005693
    [No Abstract]   [Full Text] [Related]  

  • 2. General anesthesia in a malignant hyperthermia susceptible patient.
    Jones JE; Dierdorf SF; Clapp DW
    J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of the clinical forms of malignant hyperthermia and safe anesthesia].
    Brancadoro V; Tufano R
    Minerva Anestesiol; 1992 Oct; 58(10):1009-11. PubMed ID: 1461390
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant hyperthermia: choice of anaesthesia for muscle biopsy.
    Lewis GW; Cattran C
    Can Anaesth Soc J; 1986 May; 33(3 Pt 1):419-20. PubMed ID: 3719443
    [No Abstract]   [Full Text] [Related]  

  • 5. Sufentanil-midazolam anesthesia in malignant hyperthermia.
    Tuman KJ; Spiess BD; Wong CA; Ivankovich AD
    Anesth Analg; 1988 Apr; 67(4):405-8. PubMed ID: 2895595
    [No Abstract]   [Full Text] [Related]  

  • 6. Pontocerebellar hypoplasia, malignant hyperthermia, and inappropriate use of secondary references.
    Balbi KE; Taicher BM; Litman RS
    Paediatr Anaesth; 2016 Aug; 26(8):857-8. PubMed ID: 27370523
    [No Abstract]   [Full Text] [Related]  

  • 7. Malignant hyperthermia susceptibility in patients with osteogenesis imperfecta.
    Peluso A; Cerullo M
    Paediatr Anaesth; 1995; 5(6):398-9. PubMed ID: 8597980
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple anaesthetics for a malignant hyperthermia susceptible patient.
    Emmanuel ER
    Anaesthesia; 1988 Aug; 43(8):666-70. PubMed ID: 3421459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is the prevention of peranesthetic malignant hyperthermia with dantrolene justified?].
    Welfringer P; Cornet C
    Ann Fr Anesth Reanim; 1988; 7(5):437-8. PubMed ID: 3207236
    [No Abstract]   [Full Text] [Related]  

  • 10. Propofol and malignant hyperthermia: a case for day-case anaesthesia?
    Khan KJ; Cooper GM
    Anaesthesia; 1993 May; 48(5):455-6. PubMed ID: 8317682
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
    Gallagher DM; Hyer RL
    J Oral Surg; 1980 Jun; 38(6):438-40. PubMed ID: 6929328
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignant hyperthermia--an overview.
    Dobrovolsky W
    Oral Health; 1979 Jun; 69(6):47-51, 64. PubMed ID: 397453
    [No Abstract]   [Full Text] [Related]  

  • 13. A protocol to manage malignant hyperthermia with general anesthesia.
    Roberts MW
    Pediatr Dent; 1993; 15(1):45-6. PubMed ID: 7901841
    [No Abstract]   [Full Text] [Related]  

  • 14. Temperature monitoring should be routine during general anesthesia.
    Sessler DI
    Anesthesiol Rev; 1992; 19(5):40-3. PubMed ID: 10171576
    [No Abstract]   [Full Text] [Related]  

  • 15. Routine temperature monitoring during anesthesia.
    Zsigmond EK
    JAMA; 1981 Dec; 246(23):2678. PubMed ID: 7310958
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant hyperthermia: clinical aspects, diagnosis and practical procedures].
    Urwyler A; Gerber H
    Ther Umsch; 1987 Jul; 44(7):559-63. PubMed ID: 3629538
    [No Abstract]   [Full Text] [Related]  

  • 17. Malignant hyperpyrexia: anesthesia complication.
    Stallings JO; Lines JA
    AORN J; 1975 Mar; 21(4):642, 644-5, 647. PubMed ID: 1038337
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of malignant hyperthermia susceptibility by clinical signs.
    Larach MG; Rosenberg H; Larach DR; Broennle AM
    Anesthesiology; 1987 Apr; 66(4):547-50. PubMed ID: 3565822
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant hyperthermia in a patient receiving nitrous oxide.
    Waite PD; Ballard JB; Yonfa A
    J Oral Maxillofac Surg; 1985 Nov; 43(11):907-9. PubMed ID: 3863903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of theatres for malignant hyperpyrexia patients.
    McKenzie A; Pollock N
    Anaesth Intensive Care; 1989 Nov; 17(4):510-1. PubMed ID: 2596685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.